NCT02846675View on ClinicalTrials.gov

Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

January 31, 2018

Conditions
Osteoarthritis
Interventions
BIOLOGICAL

autologous SVF

SVF will be obtained from lipoaspirates of subjects which will contain more than 5 millions nucleated cells.

BIOLOGICAL

Placebo

a Placebo treatment without SVF cells

Trial Locations (1)

200000

Shanghai East Hospital, Shanghai

All Listed Sponsors
lead

Shanghai East Hospital

OTHER

NCT02846675 - Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis | Biotech Hunter | Biotech Hunter